Other Events ·
Aptevo Therapeutics Inc. entered into a Grant Award Agreement with the Andy Hill Cancer Research Endowment (CARE) Fund…
APVOAptevo Therapeutics Inc.
Aptevo Therapeutics Inc. entered into a Grant Award Agreement with the Andy Hill Cancer Research Endowment (CARE) Fund on June 29, 2026, to receive $1,499,951.00 in reimbursement-based funding. The funds are intended to support Investigational New Drug (IND)-enabling studies for APVO451, a trispecific antibody candidate for solid tumor indications, through an expected project period ending in June 2028. Aptevo Therapeutics Inc. is a biotechnology company focused on developing therapeutic antibody candidates for cancer treatment.